Related Experiment Video

Updated: May 16, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells

Xuping Wu1, Linda Sooman, Johan Lennartsson

  • 1The Second Hospital of Nanjing affiliated to Southeast University, Nanjing, People's Republic of China. xuping_wu@yahoo.com

International Journal of Oncology
|November 24, 2012
PubMed

Insights

Microtubule targeting agents disrupt cancer cell survival and EGFR signaling. This study reveals a novel mechanism involving protein tyrosine phosphatase activation, offering potential for new combination therapies.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Microtubule targeting agents are crucial in cancer therapy, inducing cell cycle arrest and apoptosis.
  • Their mechanisms primarily involve disrupting microtubule dynamics, essential for mitosis.

Purpose of the Study:

  • To investigate the sensitivity of esophageal cancer cells to various microtubule targeting agents.
  • To elucidate the detailed cellular effects and potential novel mechanisms of action of these agents.

Main Methods:

  • Treatment of esophageal cancer cells with different microtubule targeting agents.
  • Analysis of cell survival, microtubule network integrity, and EGFR (Epidermal Growth Factor Receptor) phosphorylation.
  • Assessment of the effect of sodium orthovanadate, a tyrosine phosphatase inhibitor.

Main Results:

  • Microtubule targeting agents inhibited esophageal cancer cell survival in a dose-dependent manner.
  • These agents disrupted the microtubule network and induced dephosphorylation of EGFR.
  • EGFR dephosphorylation was reversible by sodium orthovanadate, suggesting PTP activation.

Conclusions:

  • Microtubule destabilizing agents possess an additional mechanism of action involving EGFR signaling modulation.
  • Disruption of microtubules may activate protein tyrosine phosphatases (PTPs) that regulate EGFR.
  • These findings have potential clinical relevance for developing combination therapies in esophageal cancer treatment.

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...